UPDATE: Stifel Upgrades Iovanace Biotherapeutics (IOVA) to Buy
Tweet Send to a Friend
(Updated - January 28, 2022 4:22 AM EST)
Stifel analyst Benjamin Burnett upgraded Iovanace Biotherapeutics (NASDAQ: IOVA) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Benjamin Burnett upgraded Iovanace Biotherapeutics (NASDAQ: IOVA) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
